Lung cancer prognosis: can histological patterns and morphological features have a role in the management of lung cancer patients?
作者信息
Rinaldi Silvia, Berardi Rossana
机构信息
Clinica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I, GM Lancisi, G Salesi di Ancona, Italy.
出版信息
Ann Transl Med. 2017 Sep;5(17):353. doi: 10.21037/atm.2017.05.18.
Abstract
摘要
相似文献
1
Lung cancer prognosis: can histological patterns and morphological features have a role in the management of lung cancer patients?肺癌预后：组织学模式和形态学特征在肺癌患者的治疗中能发挥作用吗？
Ann Transl Med. 2017 Sep;5(17):353. doi: 10.21037/atm.2017.05.18.
2
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.综合计算病理图像分析可预测肺癌预后。
J Thorac Oncol. 2017 Mar;12(3):501-509. doi: 10.1016/j.jtho.2016.10.017. Epub 2016 Nov 4.
3
Histological features of malignancy correlate with growth patterns and patient outcome in lung adenocarcinoma.肺腺癌中恶性肿瘤的组织学特征与生长模式和患者预后相关。
Histopathology. 2017 Sep;71(3):425-436. doi: 10.1111/his.13236. Epub 2017 Jun 16.
4
Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data.根据组织学亚型分析可切除肺腺癌预后的差异：日本肺癌登记数据的回顾性分析。
Eur J Cardiothorac Surg. 2014 Jan;45(1):100-7. doi: 10.1093/ejcts/ezt284. Epub 2013 May 31.
5
The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.混合亚型小肺癌的形态多样性与局部侵袭性和预后相关。
Eur J Cardiothorac Surg. 2011 May;39(5):763-8. doi: 10.1016/j.ejcts.2010.07.047. Epub 2010 Sep 22.
6
Histological Grade: Analysis of Prognosis of Non-small Cell Lung Cancer After Complete Resection.组织学分级：完全切除术后非小细胞肺癌的预后分析
In Vivo. 2018 Nov-Dec;32(6):1505-1512. doi: 10.21873/invivo.11407.
7
Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer.组织学对接受根治性放化疗的局部晚期非小细胞肺癌患者失败模式和临床结局的影响。
Int J Clin Oncol. 2020 Feb;25(2):274-281. doi: 10.1007/s10147-019-01566-z. Epub 2019 Oct 30.
8
Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: An autopsy study.肺癌转移灶的分布模式与原发肿瘤组织学类型的关系：一项尸检研究。
Ann Thorac Med. 2017 Jul-Sep;12(3):191-198. doi: 10.4103/atm.ATM_276_16.
9
Immunochemistry and lung cancer: application in diagnosis, prognosis and targeted therapy.免疫化学与肺癌：在诊断、预后和靶向治疗中的应用。
Oncology. 2011;80(3-4):247-56. doi: 10.1159/000329064. Epub 2011 Jul 6.
10
Histological subtypes of lung adenocarcinoma have differential ¹⁸F-fluorodeoxyglucose uptakes on the positron emission tomography/computed tomography scan.肺腺癌的组织学亚型在正电子发射断层扫描/计算机断层扫描上¹⁸F-氟脱氧葡萄糖摄取存在差异。
J Thorac Oncol. 2011 Oct;6(10):1697-703. doi: 10.1097/JTO.0b013e318226b677.
引用本文的文献
1
Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma.建立基于巨噬细胞表型转换相关特征的风险模型以预测肺腺癌的预后
Front Oncol. 2022 Feb 23;11:771988. doi: 10.3389/fonc.2021.771988. eCollection 2021.
2
Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor.根据原发性肿瘤的位置确定晚期肺腺癌的骨转移模式。
Pathol Oncol Res. 2021 Sep 23;27:1609926. doi: 10.3389/pore.2021.1609926. eCollection 2021.
3
Prognostic Value of Metabolic Tumor Parameters in Pretreatment F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Scan in Advanced Non-Small Cell Lung Cancer.代谢肿瘤参数在晚期非小细胞肺癌治疗前氟代脱氧葡萄糖正电子发射断层扫描-计算机断层扫描中的预后价值
Indian J Nucl Med. 2021 Apr-Jun;36(2):107-113. doi: 10.4103/ijnm.IJNM_170_20. Epub 2021 Jun 21.
4
Clinical value of 3'-deoxy-3'-[F]fluorothymidine-positron emission tomography for diagnosis, staging and assessing therapy response in lung cancer.3'-脱氧-3'-[F]氟胸腺嘧啶正电子发射断层扫描在肺癌诊断、分期及评估治疗反应中的临床价值
Insights Imaging. 2021 Jul 2;12(1):90. doi: 10.1186/s13244-021-01026-1.
5
The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation.双膦酸盐与放射治疗对骨转移肺腺癌的影响：KRAS 突变的作用
Transl Lung Cancer Res. 2021 Feb;10(2):675-684. doi: 10.21037/tlcr-20-754.
6
Prediction of Overall Survival of Patients with Completely Resected Non-Small Cell Lung Cancer: Analyses of Preoperative Spirometry, Preoperative Blood Tests, and Other Clinicopathological Data.完全切除的非小细胞肺癌患者总生存期的预测：术前肺功能测定、术前血液检查及其他临床病理数据的分析
Cancer Manag Res. 2019 Dec 13;11:10487-10497. doi: 10.2147/CMAR.S232219. eCollection 2019.
本文引用的文献
1
Reprogramming the lung microenvironment by inhaled immunotherapy fosters immune destruction of tumor.通过吸入式免疫疗法对肺微环境进行重编程可促进肿瘤的免疫破坏。
Oncoimmunology. 2016 Sep 20;5(11):e1234571. doi: 10.1080/2162402X.2016.1234571. eCollection 2016.
2
Prognostic considerations of the new World Health Organization classification of lung adenocarcinoma.世界卫生组织肺腺癌新分类的预后考量
Eur Respir Rev. 2016 Dec;25(142):364-371. doi: 10.1183/16000617.0089-2016.
3
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy.低钠血症正常化作为一线治疗的晚期非小细胞肺癌患者的独立预后因素。
Oncotarget. 2017 Apr 4;8(14):23871-23879. doi: 10.18632/oncotarget.13372.
4
Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.综合计算病理图像分析可预测肺癌预后。
J Thorac Oncol. 2017 Mar;12(3):501-509. doi: 10.1016/j.jtho.2016.10.017. Epub 2016 Nov 4.
5
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.
6
Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.ⅠB期肺腺癌新分类对患者的预后及预测价值
J Cancer Res Clin Oncol. 2016 Sep;142(9):2031-40. doi: 10.1007/s00432-016-2192-6. Epub 2016 Jul 5.
7
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy.预测接受一线化疗或靶向治疗的晚期非小细胞肺癌患者生存情况的预后模型。
Oncotarget. 2016 May 3;7(18):26916-24. doi: 10.18632/oncotarget.8309.
8
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.帕博利珠单抗对比多西他赛用于治疗后 PD-L1 阳性的、晚期非小细胞肺癌（KEYNOTE-010）：一项随机对照试验。
Lancet. 2016 Apr 9;387(10027):1540-1550. doi: 10.1016/S0140-6736(15)01281-7. Epub 2015 Dec 19.
9
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类：自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
10
Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.肺腺癌的亚型分类可预测完全切除术后患者辅助化疗的获益情况。
J Clin Oncol. 2015 Oct 20;33(30):3439-46. doi: 10.1200/JCO.2014.58.8335. Epub 2015 Apr 27.
Zotero 插件